+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Respiratory Drugs Market 2025-2029- Product Image
Respiratory Drugs Market 2025-2029- Product Image
New

Respiratory Drugs Market 2025-2029

  • PDF Icon

    Report

  • 226 Pages
  • March 2025
  • Region: Global
  • TechNavio
  • ID: 5576351
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The respiratory drugs market is forecasted to grow by USD 33.82 billion during 2024-2029, accelerating at a CAGR of 6.4% during the forecast period. The report on the respiratory drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the need for sustainable and safe respiratory drugs, rising prevalence of respiratory diseases, and increasing tobacco consumption.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The respiratory drugs market is segmented as below:

By Type

  • Asthma
  • COPD
  • Allergic rhinitis
  • Cystic fibrosis
  • Others

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

By Application

  • Inhalation
  • Oral
  • Injectables
  • Topical

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the emergence of telehealth and remote monitoring as one of the prime reasons driving the respiratory drugs market growth during the next few years. Also, adoption of biologics and targeted therapies and rising digital health integration will lead to sizable demand in the market.

The report on the respiratory drugs market covers the following areas:

  • Respiratory Drugs Market sizing
  • Respiratory Drugs Market forecast
  • Respiratory Drugs Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading respiratory drugs market vendors that include Abbott Laboratories, AbbVie Inc., Aerogen Pharma Ltd., AstraZeneca PLC, Aurobindo Pharma Ltd., Boehringer Ingelheim International GmbH, Celon Pharma SA, Cipla Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Laboratory Corp. of America Holdings, Lupin Ltd., Medisol Lifescience Pvt. Ltd., Merck and Co. Inc., Novartis AG, Sumitomo Pharma Co. Ltd., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Inc., and Wellona Pharma. Also, the respiratory drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Respiratory Drugs Market 2019 - 2023
Historic Market Size - Data Table on Global Respiratory Drugs Market 2019 - 2023 ($ million)
5.2 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.3 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.4 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on the Global Respiratory Drugs Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
8.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
8.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
8.3 Asthma - Market size and forecast 2024-2029
Chart on Asthma - Market size and forecast 2024-2029 ($ million)
Data Table on Asthma - Market size and forecast 2024-2029 ($ million)
Chart on Asthma - Year-over-year growth 2024-2029 (%)
Data Table on Asthma - Year-over-year growth 2024-2029 (%)
8.4 COPD - Market size and forecast 2024-2029
Chart on COPD - Market size and forecast 2024-2029 ($ million)
Data Table on COPD - Market size and forecast 2024-2029 ($ million)
Chart on COPD - Year-over-year growth 2024-2029 (%)
Data Table on COPD - Year-over-year growth 2024-2029 (%)
8.5 Allergic rhinitis - Market size and forecast 2024-2029
Chart on Allergic rhinitis - Market size and forecast 2024-2029 ($ million)
Data Table on Allergic rhinitis - Market size and forecast 2024-2029 ($ million)
Chart on Allergic rhinitis - Year-over-year growth 2024-2029 (%)
Data Table on Allergic rhinitis - Year-over-year growth 2024-2029 (%)
8.6 Cystic fibrosis - Market size and forecast 2024-2029
Chart on Cystic fibrosis - Market size and forecast 2024-2029 ($ million)
Data Table on Cystic fibrosis - Market size and forecast 2024-2029 ($ million)
Chart on Cystic fibrosis - Year-over-year growth 2024-2029 (%)
Data Table on Cystic fibrosis - Year-over-year growth 2024-2029 (%)
8.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Distribution Channel
9.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
9.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
9.3 Hospital pharmacies - Market size and forecast 2024-2029
Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
9.4 Retail pharmacies - Market size and forecast 2024-2029
Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
9.5 Online pharmacies - Market size and forecast 2024-2029
Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Application
10.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
10.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
10.3 Inhalation - Market size and forecast 2024-2029
Chart on Inhalation - Market size and forecast 2024-2029 ($ million)
Data Table on Inhalation - Market size and forecast 2024-2029 ($ million)
Chart on Inhalation - Year-over-year growth 2024-2029 (%)
Data Table on Inhalation - Year-over-year growth 2024-2029 (%)
10.4 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ million)
Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
10.5 Injectables - Market size and forecast 2024-2029
Chart on Injectables - Market size and forecast 2024-2029 ($ million)
Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
Chart on Injectables - Year-over-year growth 2024-2029 (%)
Data Table on Injectables - Year-over-year growth 2024-2029 (%)
10.6 Topical - Market size and forecast 2024-2029
Chart on Topical - Market size and forecast 2024-2029 ($ million)
Data Table on Topical - Market size and forecast 2024-2029 ($ million)
Chart on Topical - Year-over-year growth 2024-2029 (%)
Data Table on Topical - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.12 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 The Netherlands - Market size and forecast 2024-2029
Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
SWOT
15.5 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
15.6 Aerogen Pharma Ltd.
Aerogen Pharma Ltd. - Overview
Aerogen Pharma Ltd. - Product / Service
Aerogen Pharma Ltd. - Key offerings
SWOT
15.7 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
SWOT
15.8 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
SWOT
15.9 Celon Pharma SA
Celon Pharma SA - Overview
Celon Pharma SA - Product / Service
Celon Pharma SA - Key offerings
SWOT
15.10 Cipla Inc.
Cipla Inc. - Overview
Cipla Inc. - Business segments
Cipla Inc. - Key news
Cipla Inc. - Key offerings
Cipla Inc. - Segment focus
SWOT
15.11 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
15.12 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
SWOT
15.13 Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd. - Overview
Glenmark Pharmaceuticals Ltd. - Product / Service
Glenmark Pharmaceuticals Ltd. - Key offerings
SWOT
15.14 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Business segments
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
Lupin Ltd. - Segment focus
SWOT
15.15 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.16 Sumitomo Pharma Co. Ltd.
Sumitomo Pharma Co. Ltd. - Overview
Sumitomo Pharma Co. Ltd. - Business segments
Sumitomo Pharma Co. Ltd. - Key offerings
Sumitomo Pharma Co. Ltd. - Segment focus
SWOT
15.17 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
SWOT
15.18 Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc. - Overview
Vertex Pharmaceuticals Inc. - Product / Service
Vertex Pharmaceuticals Inc. - Key offerings
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Market Segmentation by Application
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Respiratory Drugs Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Type - Market share 2024-2029 (%)
Exhibits 39: Data Table on Type - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Type
Exhibits 41: Data Table on Comparison by Type
Exhibits 42: Chart on Asthma - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on Asthma - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on Asthma - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on Asthma - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on COPD - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on COPD - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on COPD - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on COPD - Year-over-year growth 2024-2029 (%)
Exhibits 50: Chart on Allergic rhinitis - Market size and forecast 2024-2029 ($ million)
Exhibits 51: Data Table on Allergic rhinitis - Market size and forecast 2024-2029 ($ million)
Exhibits 52: Chart on Allergic rhinitis - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on Allergic rhinitis - Year-over-year growth 2024-2029 (%)
Exhibits 54: Chart on Cystic fibrosis - Market size and forecast 2024-2029 ($ million)
Exhibits 55: Data Table on Cystic fibrosis - Market size and forecast 2024-2029 ($ million)
Exhibits 56: Chart on Cystic fibrosis - Year-over-year growth 2024-2029 (%)
Exhibits 57: Data Table on Cystic fibrosis - Year-over-year growth 2024-2029 (%)
Exhibits 58: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 59: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 60: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 61: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 62: Market opportunity by Type ($ million)
Exhibits 63: Data Table on Market opportunity by Type ($ million)
Exhibits 64: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits 65: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits 66: Chart on Comparison by Distribution Channel
Exhibits 67: Data Table on Comparison by Distribution Channel
Exhibits 68: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 69: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 70: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 71: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 72: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 73: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 74: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 75: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 76: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 77: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 78: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 79: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 80: Market opportunity by Distribution Channel ($ million)
Exhibits 81: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 82: Chart on Application - Market share 2024-2029 (%)
Exhibits 83: Data Table on Application - Market share 2024-2029 (%)
Exhibits 84: Chart on Comparison by Application
Exhibits 85: Data Table on Comparison by Application
Exhibits 86: Chart on Inhalation - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Data Table on Inhalation - Market size and forecast 2024-2029 ($ million)
Exhibits 88: Chart on Inhalation - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on Inhalation - Year-over-year growth 2024-2029 (%)
Exhibits 90: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 91: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 92: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 93: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 94: Chart on Injectables - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
Exhibits 96: Chart on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits 97: Data Table on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits 98: Chart on Topical - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Data Table on Topical - Market size and forecast 2024-2029 ($ million)
Exhibits 100: Chart on Topical - Year-over-year growth 2024-2029 (%)
Exhibits 101: Data Table on Topical - Year-over-year growth 2024-2029 (%)
Exhibits 102: Market opportunity by Application ($ million)
Exhibits 103: Data Table on Market opportunity by Application ($ million)
Exhibits 104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 105: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 106: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 107: Chart on Geographic comparison
Exhibits 108: Data Table on Geographic comparison
Exhibits 109: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 150: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 151: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 153: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 154: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 155: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 156: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 157: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 158: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 159: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 160: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 161: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibits 162: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibits 163: Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibits 164: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibits 165: Market opportunity By Geographical Landscape ($ million)
Exhibits 166: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 167: Impact of drivers and challenges in 2024 and 2029
Exhibits 168: Overview on criticality of inputs and factors of differentiation
Exhibits 169: Overview on factors of disruption
Exhibits 170: Impact of key risks on business
Exhibits 171: Companies covered
Exhibits 172: Company ranking index
Exhibits 173: Matrix on companies position and classification
Exhibits 174: Abbott Laboratories - Overview
Exhibits 175: Abbott Laboratories - Business segments
Exhibits 176: Abbott Laboratories - Key news
Exhibits 177: Abbott Laboratories - Key offerings
Exhibits 178: Abbott Laboratories - Segment focus
Exhibits 179: SWOT
Exhibits 180: AbbVie Inc. - Overview
Exhibits 181: AbbVie Inc. - Product / Service
Exhibits 182: AbbVie Inc. - Key news
Exhibits 183: AbbVie Inc. - Key offerings
Exhibits 184: SWOT
Exhibits 185: Aerogen Pharma Ltd. - Overview
Exhibits 186: Aerogen Pharma Ltd. - Product / Service
Exhibits 187: Aerogen Pharma Ltd. - Key offerings
Exhibits 188: SWOT
Exhibits 189: AstraZeneca Plc - Overview
Exhibits 190: AstraZeneca Plc - Product / Service
Exhibits 191: AstraZeneca Plc - Key news
Exhibits 192: AstraZeneca Plc - Key offerings
Exhibits 193: SWOT
Exhibits 194: Boehringer Ingelheim International GmbH -

Executive Summary

The following companies are recognized as the key players in the global respiratory drugs market: Abbott Laboratories, AbbVie Inc., Aerogen Pharma Ltd., AstraZeneca Plc, Aurobindo Pharma Ltd., Boehringer Ingelheim International GmbH, Celon Pharma SA, Cipla Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Laboratory Corp. of America Holdings, Lupin Ltd., Medisol Lifescience Pvt. Ltd., Merck and Co. Inc., Novartis AG, Sumitomo Pharma Co. Ltd., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Inc., and Wellona Pharma.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is emergence of telehealth and remote monitoring."

According to the report, one of the major drivers for this market is the need for sustainable and safe respiratory drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AbbVie Inc.
  • Aerogen Pharma Ltd.
  • AstraZeneca Plc
  • Aurobindo Pharma Ltd.
  • Boehringer Ingelheim International GmbH
  • Celon Pharma SA
  • Cipla Inc.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd.
  • Laboratory Corp. of America Holdings
  • Lupin Ltd.
  • Medisol Lifescience Pvt. Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • Sumitomo Pharma Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Vertex Pharmaceuticals Inc.
  • Wellona Pharma

Related Topics

Related Reports

Respiratory Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Respiratory Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • 150 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease Drugs Market 2024-2028 - Product Image

Chronic Obstructive Pulmonary Disease Drugs Market 2024-2028

  • Report
  • 168 Pages
  • Global
From
Pulmonary Edema Therapeutics Market 2024-2028 - Product Image

Pulmonary Edema Therapeutics Market 2024-2028

  • Report
  • 145 Pages
  • Global
From
Pulmonary Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Pulmonary Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • 150 Pages
  • Global
From
Budesonide Global Market Report 2025 - Product Image

Budesonide Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.